Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion

被引：156

作者：

de Wilt, JHW

ten Hagen, TLM

de Boeck, G

van Tiel, ST

de Bruijn, EA

Eggermont, AMM

机构：

[1] Univ Hosp Rotterdam Dijkzigt, Daniel den Hoed Canc Ctr, Dept Surg Oncol, NL-3075 EA Rotterdam, Netherlands

[2] Univ Antwerp, Organ Chem Lab, B-2020 Antwerp, Belgium

[3] Katholieke Univ Leuven, Expt Oncol Lab, Louvain, Belgium

来源：

BRITISH JOURNAL OF CANCER | 2000年 / 82卷 / 05期

关键词：

TNF; melphalan; tissue concentration; isolated limb perfusion; rats;

D O I：

10.1054/bjoc.1999.1032

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Several possible mechanisms for the synergistic anti-tumour effects between tumour necrosis factor alpha (TNF-alpha) and melphalan after isolated limb perfusion (ILP) have been presented. We found a significant sixfold increase in melphalan tumour tissue concentration after ILP when TNF-alpha was added to the perfusate, which provides a straightforward explanation for the observed synergism between melphalan and TNF-alpha in ILP. (C) 2000 Cancer Research Campaign.

引用

页码：1000 / 1003

页数：4

共 26 条

[11] HIGH-DOSE RECOMBINANT TUMOR-NECROSIS-FACTOR-ALPHA IN COMBINATION WITH INTERFERON-GAMMA AND MELPHALAN IN ISOLATION PERFUSION OF THE LIMBS FOR MELANOMA AND SARCOMA [J].

LIENARD, D ;

EWALENKO, P ;

DELMOTTE, JJ ;

RENARD, N ;

LEJEUNE, FJ .

JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (01) :52-60

[12] Assessment of the role of neutrophils on the antitumor effect of TNFα in an in vivo isolated limb perfusion model in sarcoma-bearing brown Norway rats [J].

Manusama, ER ;

Nooijen, PTGA ;

Stavast, J ;

de Wilt, JHW ;

Marquet, RL ;

Eggermont, AMM .

JOURNAL OF SURGICAL RESEARCH, 1998, 78 (02) :169-175

[13] Synergistic antitumour effect of recombinant human tumour necrosis factor alpha with melphalan in isolated limb perfusion in the rat [J].

Manusama, ER ;

Nooijen, PTGA ;

Stavast, J ;

Durante, NMC ;

Marquet, RL ;

Eggermont, AMM .

BRITISH JOURNAL OF SURGERY, 1996, 83 (04) :551-555

[14] THERAPEUTIC EFFECTS OF LIPOSOMAL ADRIAMYCIN IN COMBINATION WITH TUMOR-NECROSIS-FACTOR-ALPHA [J].

MARUO, Y ;

KONNO, H ;

BABA, S .

JOURNAL OF SURGICAL ONCOLOGY, 1992, 49 (01) :20-24

[15] Synergistic effects of TNF-alpha and melphalan in an isolated limb perfusion model of rat sarcoma: A histopathological, immunohistochemical and electron microscopical study [J].

Nooijen, PTGA ;

Manusama, ER ;

Eggermont, AMM ;

Schalkwijk, L ;

Stavast, J ;

Marquet, RL ;

deWaal, RMW ;

Ruiter, DJ .

BRITISH JOURNAL OF CANCER, 1996, 74 (12) :1908-1915

[16] ISOLATED LUNG PERFUSION WITH TUMOR-NECROSIS-FACTOR - A SWINE MODEL IN PREPARATION OF HUMAN TRIALS [J].

POGREBNIAK, HW ;

WITT, CJ ;

TERRILL, R ;

KRANDA, K ;

TRAVIS, WD ;

ROSENBERG, SA ;

PASS, HI .

ANNALS OF THORACIC SURGERY, 1994, 57 (06) :1477-1483

[17]

POSNER M, 1994, P AN M AM SOC CLIN, V13, P1351

[18] VWF RELEASE AND PLATELET-AGGREGATION IN HUMAN-MELANOMA AFTER PERFUSION WITH TNF-ALPHA [J].

RENARD, N ;

NOOIJEN, BTGA ;

SCHALKWIJK, L ;

DEWAAL, RMW ;

EGGERMONT, AMM ;

LIENARD, D ;

KROON, BBR ;

LEJEUNE, FJ ;

RUITER, DJ .

JOURNAL OF PATHOLOGY, 1995, 176 (03) :279-287

[19] EARLY ENDOTHELIUM ACTIVATION AND POLYMORPHONUCLEAR CELL INVASION PRECEDE SPECIFIC NECROSIS OF HUMAN-MELANOMA AND SARCOMA TREATED BY INTRAVASCULAR HIGH-DOSE TUMOR-NECROSIS-FACTOR-ALPHA (RTNF-ALPHA) [J].

RENARD, N ;

LIENARD, D ;

LESPAGNARD, L ;

EGGERMONT, A ;

HEIMANN, R ;

LEJEUNE, F .

INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (05) :656-663

[20] Isolated hepatic perfusion in the pig with TNF-alpha with and without melphalan [J].

Rinkes, IHMB ;

deVries, MR ;

Jonker, AM ;

Swaak, TJG ;

Hack, CE ;

Nooyen, PTGA ;

Wiggers, T ;

Eggermont, AMM .

BRITISH JOURNAL OF CANCER, 1997, 75 (10) :1447-1453

← 1 2 3 →